Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600546 · ClinicalTrials.gov registry record
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT
A clinical trial of Repeatability & Reproducibility, sponsored by Optovue.
- Completed
- Registry status
- 62
- Enrollment target
- 1
- Study location
NCT02600546 is a study of Repeatability & Reproducibility that has completed, run by Optovue. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02600546, a study of Repeatability & Reproducibility, has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the repeatability and reproducibility of the RTVue-XR for measuring the total corneal thickness (pachymetry), the epithelial thickness, and the stromal thickness mapping in normal subjects and corneal patients.
Conditions Studied
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02600546
The ClinicalTrials.gov registry entry for NCT02600546 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optovue, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Repeatability & Reproducibility appearing as the primary indexed condition, and to 0 interventions.
NCT02600546 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02600546 about?
NCT02600546 is a clinical study titled "Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT". Evaluate the repeatability and reproducibility of the RTVue-XR for measuring the total corneal thickness (pachymetry), the epithelial thickness, and the stromal thickness mapping in normal subjects and corneal patients.
What is the current status of trial NCT02600546?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2015-10. Estimated completion is 2016-02.
What conditions does trial NCT02600546 study?
This clinical trial studies the following conditions: Repeatability & Reproducibility.
Who is sponsoring clinical trial NCT02600546?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02600546 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.